CDKN1Bmt
| Product | Unit size | Cat. code | Docs. | Qty. | Price | |
|---|---|---|---|---|---|---|
|
pUNO1-hCDKN1Bmt pUNO1 bearing the human CDKN1Bmt (p27mt) gene |
Show product |
20 µg |
puno1-hcdkn1bmt
|
|
Expression-ready ORF Clones
Alias : p27, KIP1, CDKN4
Cyclin-dependent kinase inhibitor 1B.
CDKN1Bmt (p27mt) is a cyclin-dependent kinase inhibitor mutant harboring T187M & P188I mutations.
This engineered CDKN1B was described as having a better anti-tumor effect [1].
1. Park KH et al. 2004 Application of p27 gene therapy for human malignant glioma potentiated by using mutant p27. J Neurosurg. 101(3):505-10.
Back to the topSpecifications
Human CDKN1Bmt (pUNO1-hCDKN1Bmt)
ORF size : 597 bp
Subclone : AgeI - NheI
pUNO1 Contents
- 20 µg of lyophilized DNA
- 2 x 1 ml blasticidin at 10 mg/ml
Product is shipped at room temperature.
Lyophilized DNA should be stored at -20°C. Upon receipt, store blasticidin at 4°C or -20°C.
Resuspended DNA should be stored at -20°C and is stable for up to 1 year.
Blasticidin is a harmful compound. Refer to the safety data sheet for handling instructions.